Developer docs
API playgroundTry for free, no card

Search company profiles

Regulus

Full company profile

uuid002l879

Namestring
Regulus
Legal namestring
Regulus Inc. ( レギュラス株式会社 )
Websiteurl
cro.co.jp
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Regulus Inc. (レギュラス株式会社) is a Tokyo-based, privately-held medical imaging contract research organization (CRO) that delivers specialized imaging core lab services for clinical trials conducted by pharmaceutical companies, medical device manufacturers, and investigator-led research groups. The firm provides an end-to-end, six-step workflow (STEP1-6) covering imaging procedure documentation, photography consulting, anonymized image data transfer, image quality control, central image adjudication committee management, quantitative image analysis on workstations, and final report delivery. Each step can be contracted individually or as a full package, supplemented by a remote image central adjudication service introduced in 2021 that allows diagnostic radiologists to evaluate trial images without physical travel.

The company is staffed by approximately 15 full-time employees, including licensed radiological technologists with prior hospital clinical experience, supported by a curated network of 54 diagnostic radiologists across therapeutic areas including oncology, cardiovascular, respiratory, and urology. Regulus has accumulated roughly 15 years of operational history (originating from a predecessor imaging-focused CRO around 2008-2009), reporting 165+ commissioned projects and 121+ clinical trial protocols completed across Japan with stated capability to support global studies.

The business operates on a project-based professional services model with custom, multi-year contracts priced according to scope; pricing is not publicly disclosed. The go-to-market is direct enterprise sales targeting pharma clinical development teams, medical device regulatory affairs groups, and academic investigators, conducted primarily in Japan with a domestic focus on the Kanto region. On June 21, 2024, Regulus became a wholly-owned subsidiary of PSP Corporation (PSP株式会社) as part of a strategic business and capital partnership, while continuing to operate as an independent service provider.

Short descriptiontext

Regulus is a Tokyo-based medical imaging CRO providing end-to-end imaging core lab services, including central adjudication and remote reading, for clinical trials run by pharmaceutical companies, medical device manufacturers, and academic researchers in Japan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging CRO, clinical trial imaging, central image adjudication, imaging core lab services, radiology adjudication services
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Medical Imaging CRO / Clinical Research Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1医用イメージングCROサービス (Imaging CRO Services)
TypeProfessional Services
Description

Project-based services for pharmaceutical companies, medical device manufacturers, and research institutions. Services include central image adjudication committees, image data management, photography consultation, and image analysis. Projects can be contracted as full end-to-end packages (STEP1-6) or individual services.

cro.co.jp
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Services can be contracted as full end-to-end packages or individual steps. Budget-appropriate support available - even image adjudication committee hosting only is accepted. Pricing determined based on project scope and requirements.

cro.co.jp
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Regulus provides specialized medical imaging contract research organization (CRO) services for pharmaceutical, medical device, and clinical research clients. The offerings cover the full imaging workflow—from protocol/photography manual creation, shooting consulting, data transfer and anonymization, image quality control, and central image adjudication committee management to quantitative image analysis and final report delivery. Services can be purchased as individual workflow steps or as an integrated end-to-end package, with a remote image central reading option for distributed adjudication.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 165+ commissioned projects completed nationally
+3 more records
Product overview1 text field

Regulus is a specialized medical imaging CRO (Contract Research Organization) offering integrated imaging core lab services for clinical trials and clinical research. The company operates as a single unified service platform with a modular six-step workflow (STEP1-6) covering imaging protocol development, shooting consulting, data transfer, quality control, central image reading management, and image analysis. The core Medical Imaging CRO Services serve as the primary offering, supplemented by a Remote Image Central Reading Service for remote evaluations. Clients can engage individual steps or the full end-to-end service package.

Product and service2 records
1Medical Imaging CRO Services (医用イメージングCRO業務)
CategoryClinical Research / Imaging CRO
Description

A specialized contract research organization service focused on medical imaging for clinical trials, providing end-to-end support from imaging protocol setup through central image reading and analysis for pharmaceutical companies, medical device manufacturers, and research institutions.

2Remote Image Central Reading Service (遠隔画像中央判定サービス)
CategoryClinical Research / Imaging CRO
Description

A remote-based image central adjudication service that allows radiologists and physicians to evaluate medical images without physically traveling to a centralized location, reducing costs and providing flexible scheduling for image central reading committee meetings in pharmaceutical, medical device, and investigator-initiated clinical trials.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medpace is a global CRO with in-house imaging core lab capabilities serving mid-sized pharmaceutical and biotech sponsors. Its full-service model and therapeutic area expertise in oncology, cardiovascular, and metabolic diseases compete with Regulus's specialty focus.

TypeBroad incumbent
Description

Clario is a global leader in clinical trial imaging and endpoint solutions, formed through the merger of Bioclinica and ERT. It is the dominant imaging CRO globally and competes directly with Regulus in medical imaging core lab services, though at a much larger scale and with broader geographic coverage.

TypeDirect peer
Description

CMIC is Japan's largest CRO, offering comprehensive clinical development services including imaging support. As a domestic peer with full-service trial capabilities, CMIC competes with Regulus for Japanese pharmaceutical clients, though Regulus's pure-play imaging focus is its differentiation.

TypeDirect peer
Description

Imaging Endpoints is a specialized global imaging CRO providing image analysis, central reading, and reader management for oncology clinical trials. It is a direct competitor in the pure-play imaging CRO space where Regulus operates, with broader therapeutic focus on oncology.

TypeBroad incumbent
Description

Parexel is a major global CRO offering comprehensive clinical development services including imaging capabilities. It competes with Regulus for pharmaceutical sponsor work, particularly for international trials where Parexel's global footprint offers advantages.

6EPS Holdings
TypeDirect peer
Description

EPS Holdings is a major Japanese CRO providing clinical trial support services including imaging-related services to pharmaceutical companies. It is a direct competitor in the Japanese market with broader service offerings across the clinical development lifecycle.

TypeBroad incumbent
Description

ICON plc is one of the world's largest CROs, having acquired PRA Health Sciences, and offers imaging services through its dedicated Medical Imaging group. It competes with Regulus for global pharmaceutical trial imaging work, particularly for large Phase III programs.

TypeEmerging player
Description

Median Technologies provides imaging solutions for oncology clinical trials, including AI-based image analysis. As an emerging imaging-focused company with technology emphasis, it represents both a competitor and adjacent player to Regulus's imaging CRO services.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO and life sciences services provider, offering imaging core lab services through its dedicated technology and analytics functions. It competes broadly with Regulus for global pharmaceutical sponsor imaging work, especially for large integrated trial programs.

10Bell Medical Solutions
TypeDirect peer
Description

Bell Medical Solutions is a Japanese CRO focused on clinical trial support including medical imaging services. It is a direct domestic competitor to Regulus with overlapping customer base among Japanese pharmaceutical companies and similar specialization in imaging-related CRO services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regulus

Medical Imaging CRO / Clinical Research Servicescro.co.jp

Regulus is a Tokyo-based medical imaging CRO providing end-to-end imaging core lab services, including central adjudication and remote reading, for clinical trials run by pharmaceutical companies, medical device manufacturers, and academic researchers in Japan.

What Regulus does

Regulus Inc. (レギュラス株式会社) is a Tokyo-based, privately-held medical imaging contract research organization (CRO) that delivers specialized imaging core lab services for clinical trials conducted by pharmaceutical companies, medical device manufacturers, and investigator-led research groups. The firm provides an end-to-end, six-step workflow (STEP1-6) covering imaging procedure documentation, photography consulting, anonymized image data transfer, image quality control, central image adjudication committee management, quantitative image analysis on workstations, and final report delivery. Each step can be contracted individually or as a full package, supplemented by a remote image central adjudication service introduced in 2021 that allows diagnostic radiologists to evaluate trial images without physical travel.

The company is staffed by approximately 15 full-time employees, including licensed radiological technologists with prior hospital clinical experience, supported by a curated network of 54 diagnostic radiologists across therapeutic areas including oncology, cardiovascular, respiratory, and urology. Regulus has accumulated roughly 15 years of operational history (originating from a predecessor imaging-focused CRO around 2008-2009), reporting 165+ commissioned projects and 121+ clinical trial protocols completed across Japan with stated capability to support global studies.

The business operates on a project-based professional services model with custom, multi-year contracts priced according to scope; pricing is not publicly disclosed. The go-to-market is direct enterprise sales targeting pharma clinical development teams, medical device regulatory affairs groups, and academic investigators, conducted primarily in Japan with a domestic focus on the Kanto region. On June 21, 2024, Regulus became a wholly-owned subsidiary of PSP Corporation (PSP株式会社) as part of a strategic business and capital partnership, while continuing to operate as an independent service provider.

Regulus firmographics

Firmographics
Name
Regulus
Legal name
Regulus Inc. ( レギュラス株式会社 )
Website
https://cro.co.jp
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Regulus is a Tokyo-based medical imaging CRO providing end-to-end imaging core lab services, including central adjudication and remote reading, for clinical trials run by pharmaceutical companies, medical device manufacturers, and academic researchers in Japan.
Ownership category
akta.pro rank

Regulus industry classification

Industry
Product category
Medical Imaging CRO / Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Medical imaging CRO
  • Clinical trial imaging
  • Central image adjudication
  • Imaging core lab services
  • Radiology adjudication services

Where Regulus is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

Regulus business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. 医用イメージングCROサービス (Imaging CRO Services): Project-based services for pharmaceutical companies, medical device manufacturers, and research institutions. Services include central image adjudication committees, image data management, photography consultation, and image analysis. Projects can be contracted as full end-to-end packages (STEP1-6) or individual services.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels2 records

Regulus product offering

Product offering

Core offering

Regulus provides specialized medical imaging contract research organization (CRO) services for pharmaceutical, medical device, and clinical research clients. The offerings cover the full imaging workflow—from protocol/photography manual creation, shooting consulting, data transfer and anonymization, image quality control, and central image adjudication committee management to quantitative image analysis and final report delivery. Services can be purchased as individual workflow steps or as an integrated end-to-end package, with a remote image central reading option for distributed adjudication.

Product overview

Regulus is a specialized medical imaging CRO (Contract Research Organization) offering integrated imaging core lab services for clinical trials and clinical research. The company operates as a single unified service platform with a modular six-step workflow (STEP1-6) covering imaging protocol development, shooting consulting, data transfer, quality control, central image reading management, and image analysis. The core Medical Imaging CRO Services serve as the primary offering, supplemented by a Remote Image Central Reading Service for remote evaluations. Clients can engage individual steps or the full end-to-end service package.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Imaging CRO Services (医用イメージングCRO業務) A specialized contract research organization service focused on medical imaging for clinical trials, providing end-to-end support from imaging protocol setup through central image reading and analysis for pharmaceutical companies, medical device manufacturers, and research institutions.
  • Remote Image Central Reading Service (遠隔画像中央判定サービス) A remote-based image central adjudication service that allows radiologists and physicians to evaluate medical images without physically traveling to a centralized location, reducing costs and providing flexible scheduling for image central reading committee meetings in pharmaceutical, medical device, and investigator-initiated clinical trials.

Quantifiable outcome

  • 165+ commissioned projects completed nationally
  • +3 more outcomes

Companies that use Regulus

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Regulus technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Regulus partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

Regulus competitors and assessment

Company assessment

Broad incumbents

  • Medpace: Medpace is a global CRO with in-house imaging core lab capabilities serving mid-sized pharmaceutical and biotech sponsors. Its full-service model and therapeutic area expertise in oncology, cardiovascular, and metabolic diseases compete with Regulus's specialty focus.
  • Clario (formerly Bioclinica): Clario is a global leader in clinical trial imaging and endpoint solutions, formed through the merger of Bioclinica and ERT. It is the dominant imaging CRO globally and competes directly with Regulus in medical imaging core lab services, though at a much larger scale and with broader geographic coverage.
  • Parexel: Parexel is a major global CRO offering comprehensive clinical development services including imaging capabilities. It competes with Regulus for pharmaceutical sponsor work, particularly for international trials where Parexel's global footprint offers advantages.
  • ICON plc: ICON plc is one of the world's largest CROs, having acquired PRA Health Sciences, and offers imaging services through its dedicated Medical Imaging group. It competes with Regulus for global pharmaceutical trial imaging work, particularly for large Phase III programs.
  • IQVIA: IQVIA is the world's largest CRO and life sciences services provider, offering imaging core lab services through its dedicated technology and analytics functions. It competes broadly with Regulus for global pharmaceutical sponsor imaging work, especially for large integrated trial programs.

Direct peers

  • CMIC Holdings: CMIC is Japan's largest CRO, offering comprehensive clinical development services including imaging support. As a domestic peer with full-service trial capabilities, CMIC competes with Regulus for Japanese pharmaceutical clients, though Regulus's pure-play imaging focus is its differentiation.
  • Imaging Endpoints: Imaging Endpoints is a specialized global imaging CRO providing image analysis, central reading, and reader management for oncology clinical trials. It is a direct competitor in the pure-play imaging CRO space where Regulus operates, with broader therapeutic focus on oncology.
  • EPS Holdings: EPS Holdings is a major Japanese CRO providing clinical trial support services including imaging-related services to pharmaceutical companies. It is a direct competitor in the Japanese market with broader service offerings across the clinical development lifecycle.
  • Bell Medical Solutions: Bell Medical Solutions is a Japanese CRO focused on clinical trial support including medical imaging services. It is a direct domestic competitor to Regulus with overlapping customer base among Japanese pharmaceutical companies and similar specialization in imaging-related CRO services.

Emerging players

  • Median Technologies: Median Technologies provides imaging solutions for oncology clinical trials, including AI-based image analysis. As an emerging imaging-focused company with technology emphasis, it represents both a competitor and adjacent player to Regulus's imaging CRO services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Regulus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regulus leadership team

Management profile

Number of profiles

Profiles1 record

Regulus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regulus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regulus

What does Regulus do?

Regulus provides specialized medical imaging contract research organization (CRO) services for pharmaceutical, medical device, and clinical research clients. The offerings cover the full imaging workflow—from protocol/photography manual creation, shooting consulting, data transfer and anonymization, image quality control, and central image adjudication committee management to quantitative image analysis and final report delivery. Services can be purchased as individual workflow steps or as an integrated end-to-end package, with a remote image central reading option for distributed adjudication.

Is Regulus a public or private company?

Regulus is a private company. It is classified as corporate owned and is currently operating.

When was Regulus founded?

Regulus was founded in 2008. It employs 11 to 50 people.

Where is Regulus based?

Regulus is headquartered in Tokyo, Japan, in the Asia region.

How does Regulus make money?

One revenue line is on record: 医用イメージングCROサービス (Imaging CRO Services).

Who are Regulus's main competitors?

Broad incumbents on record are Medpace, Clario (formerly Bioclinica), Parexel, ICON plc and IQVIA. Direct peers are CMIC Holdings, Imaging Endpoints, EPS Holdings and Bell Medical Solutions. Median Technologies is listed as an emerging player.

Does Regulus have an API?

No public API is recorded for Regulus.

What industry is Regulus in?

Regulus's product category is Medical Imaging CRO / Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 5417 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals